In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from study for monitoring antimicrobial resistance trends (SMART)

Surgical Infections

Volumn 10, Issue 2, 2009, Pages 99-104

  Baquero, Fernando ^a   Hsueh, Po Ren ^b   Paterson, David L ^c   Rossi, Flvia ^d   Bochicchio, Grant V ^e   Gallagher, Gale ^f   Lantz, Keith ^f   Villasenor, Javier Baez ^f   McCarroll, Kathleen ^f   Abramson, Murray A ^f   Chow, Joseph W ^f,g  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

^f MERCK RESEARCH LABORATORIES   (United States)

^g UG3D 56 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLAVULANIC ACID; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BROTH DILUTION; CONTROLLED STUDY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HEALTH CENTER; HUMAN; IN VITRO STUDY; KLEBSIELLA; MONITORING; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SPECIES;

ABDOMINAL CAVITY; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; GRAM-NEGATIVE AEROBIC BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS; HUMANS; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; WORLD HEALTH;

EID: 66249145416     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2008.0020     Document Type: Article

References (15)

1. Levy SB, Marshall B. Antibacterial resistance worldwide: Causes, challenges and responses. Nat Med 2004;10(12 Suppl):S122-S129. (Pubitemid 40018235)
2. Sahm DF, Marsilio MK, Piazza G. Antimicrobial resistance in key bloodstream bacterial isolates: Electronic surveillance with the Surveillance Network Database-USA. Clin Infect Dis 1999;29:259-263. (Pubitemid 29380180)
3. Jones RN. The emergent needs for basic research, education, and surveillance of antimicrobial resistance: Problems facing the report from the American Society for Microbiology Task Force on Antibiotic Resistance. Diagn Microbiol Infect Dis 1996;25:153-161. (Pubitemid 26392166)
4. Paterson DL, Rossi F, Baquero F, et al. In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: The 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother 2005;55:965-973.
5. Thomson KS. Controversies about extended-spectrum and AmpC beta-lactamases. Emerg Infect Dis 2001;7:333-336. (Pubitemid 32374356)
6. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: Tenth informational supplement (aerobic dilution). Vil-lanova, PA. National Committee for Clinical Laboratory Standards; 2000.
7. Tzouvelekis LS, Vatopoulos AC, Katsanis G, Tzelepi E. Rare case of failure by an automated system to detect extended-spectrum beta-lactamase in a cephalosporin-resistant Klebsiella pneumoniae isolate. J Clin Microbiol 1999;37:2388.
8. Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med 1985;4:213-226 (Pubitemid 15055349)
9. Fraser A, Paul M, Almanasreh N, et al. Benefit of appropriate empirical antibiotic treatment: Thirty-day mortality and duration of hospital stay. Am J Med 2006;119:970-976.
10. Felmingham D, Gruneberg RN. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project. J Antimicrob Chemother 1996;38 Suppl A:l-57.
11. Pfaller MA, Jones RN, Doern GV, Kugler K. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998;42:1762-1770.
12. Turner PJ, Greenhalgh JM, Edwards JR, McKellar J. The MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) programme. Int J Antimicrob Agents 1999; 13:117-125. (Pubitemid 29492911)
13. Chow JW, Satishchandran V, Snyder TA, et al. In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: The 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect 2005;6:439-448.
14. Rossi F, Baquero F, Hsueh PR, et al. In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother 2006;58:205-210.
15. Bochicchio GV, Baquero F, Hsueh PR, et al. In vitro susceptibilities of Escherichia coli isolated from patients with intraabdominal infections worldwide in 2002-2004: Results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Surg Infect 2006;7:537-545.